Trials / Unknown
UnknownNCT05852028
A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma
A Real-world Study: Efficacy and Safety of Selinexor-based Regimens for Non-Hodgkin Lymphoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims to observe and explore the efficacy and safety of selinexor-based regimen in patients with Non-Hodgkin lymphoma
Detailed description
this study aims to observe and explore the efficacy and safety of selinexor-based regimen in patients with DLBCL or T cell lymphoma. This study is a non-interventional real world, observational study and all registered data are collected from real clinical practice cases. The medical data includes patient demographic, tumor characteristics, laboratory examination, history of treatments, adverse reactions, efficacy results and possible prognostic factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Selinexor | this is a real-world. Patients who use selinexor-based regimens in lymphoma will be followed up without interfering with the choice of treatment options for patients |
Timeline
- Start date
- 2022-12-15
- Primary completion
- 2024-10-10
- Completion
- 2025-10-18
- First posted
- 2023-05-10
- Last updated
- 2023-05-10
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05852028. Inclusion in this directory is not an endorsement.